 Emerging SARS-CoV-2 mutants may escape neutralization by antibodies. Here, the authors use deep mutational scanning to identify mutations in the R-BD that escape human monoclonal antibodies, or convalescent plasmas. This article was authored by Allison J. Greeny, Tyler N. Starr, Christopher O. Barnes, and others.